This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
IntriCon Corporation(NasdaqGM:IIN) dropped from S&P TMI Index CI
IntriCon Corporation(NasdaqGM:IIN) dropped from S&P Global BMI Index CI
Intricon Corporation Announces Board Changes CI
IntriCon Corporation(NasdaqGM:IIN) dropped from NASDAQ Composite Index CI
Altaris Capital Partners, LLC completed the acquisition of IntriCon Corporation from Gabelli Funds, LLC, Beryl Capital Management LLC, Royce & Associates, LP and others. CI
IntriCon Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Sector Update: Health Care Stocks Finishing Above Intraday Lows MT
Colliers Securities Downgrades IntriCon to Neutral From Buy MT
Top Midday Gainers MT
Sector Update: Health Care Stocks Sinking Monday But Biotechs, Deal-Making Helping Limit Slide MT
Intricon Agrees to be Acquired by Altaris Capital Partners for $241 Million; Shares Surge Premarket MT
IntriCon Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
IntriCon Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2021 CI
Earnings Flash (IIN) INTRICON CORPORATION Reports Q4 Revenue $32.2M MT
Earnings Flash (IIN) INTRICON CORPORATION Reports Q4 EPS $0.23 MT
Altaris Capital Partners, LLC entered into a definitive agreement to acquire IntriCon Corporation from Gabelli Funds, LLC, Beryl Capital Management LLC, Royce & Associates, LP and others for approximately $230 million. CI
Ellen Scipta Steps Down as Chief Financial Officer CI
Transcript : IntriCon Corporation, Q3 2021 Earnings Call, Nov 08, 2021
Earnings Flash (IIN) INTRICON CORPORATION Reports Q3 Revenue $31.1M, vs. Street Est of $31.1M MT
Earnings Flash (IIN) INTRICON CORPORATION Posts Q3 EPS $0.17, vs. Street Est of $0.02 MT
IntriCon Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
IntriCon Corporation Revises Revenue Guidance for the Year 2021 CI
IntriCon CFO Steps Down; Reports Preliminary Q3 Revenue MT
IntriCon Corporation Announces CFO Changes CI
IntriCon Corporation Announces Revenue Guidance for the Quarter ended September 30, 2021 CI
Chart IntriCon Corporation
More charts
Intricon Corporation is a joint development manufacturer (JDM) of micro medical components, sub-assemblies and final devices. The Company serves as a JDM partner to medical device original equipment manufacturers (OEMs) by designing, developing, engineering, manufacturing, packaging and distributing micro medical devices components and subassemblies for medical markets, such as diabetes, peripheral vascular, interventional pulmonology, electrophysiology and hearing healthcare. It manufactures microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components and complete catheter-based and body-worn devices for medical device manufacturers. The Company serves its market by offering medical device manufacturers, which have the capabilities to design, develop, manufacture, package and distribute medical devices. It operates globally with facilities in Minnesota, Illinois, California, Singapore, Indonesia and Germany.
More about the company
  1. Stock Market
  2. Equities
  3. IIN Stock
  4. News IntriCon Corporation
  5. Earnings Flash (IIN) INTRICON CORPORATION Reports Q3 Revenue $31.1M, vs. Street Est of $31.1M